Results 91 to 100 of about 1,942,013 (293)
Cutaneous Eruptions Associated With Tumour Infiltrating Lymphocyte Therapy: A Case Series
ABSTRACT Tumour‐infiltrating lymphocyte (TIL) therapy is a newly emerged effective treatment for advanced melanoma refractory to immune checkpoint inhibitors; however, its cutaneous adverse effects remain uncharacterized. We present the first case series describing dermatologic adverse effects associated with TIL therapy for malignant melanoma in five ...
Shannon C. Lyden +9 more
wiley +1 more source
Hydroxychloroquine-induced repetitive atypical pustular drug eruptions in the same patient separated by 12 years. [PDF]
Chen J +4 more
europepmc +1 more source
ABSTRACT Background Subcorneal pustular dermatosis (SPD), or Sneddon–Wilkinson disease, is a rare, relapsing pustular skin condition of unknown cause, characterised by subcorneal pustules. Objectives To summarise the demographic, clinical, histopathological, management and disease course of SPD.
Mason H. Crossman +5 more
wiley +1 more source
Fixed Drug Eruption with Pigmentation Induced by Etoricoxib: A Case Report
Fixed drug eruption with pigmentation is characterized by the appearance of erythematous or bullous lesions following the ingestion of certain medications.
Dextre-Vilchez, Sergio Armando +1 more
doaj +1 more source
Pseudoephedrine-induced Fixed Drug Eruption in a Scuba Diver With Recurrent Palmoplantar Exfoliation [PDF]
This report presents a case of pseudoephedrine-induced non-pigmented bullous fixed drug eruption (NBFDE) manifesting as recurrent palmoplantar exfoliation in a scuba diver.
Pimpreeya Kajornchaikul +2 more
doaj +1 more source
Fixed Drug Eruptions With Flavoured Liquid Formulations of Over-the-Counter Analgesics: A Case Report. [PDF]
Alzahrani AH.
europepmc +1 more source
Multiple fixed drug eruptions [PDF]
Fixed drug eruptions (FDE) are a type of hypersensitivity reaction that occurs in response to certain medications, typically reappearing at the same site when the causative drug is reintroduced.
Muzaffer, Maliha +2 more
core +1 more source
Pembrolizumab‐Induced Subacute Cutaneous Lupus Erythematosus: A Case Report
ABSTRACT Subacute cutaneous lupus erythematosus (SCLE) is an increasingly recognized cutaneous immune‐related adverse event of immune checkpoint inhibitors. We report an 83‐year‐old woman who developed pruritic annular and polycyclic plaques 10 weeks after starting pembrolizumab for oropharyngeal squamous cell carcinoma.
Sebastiano Posenato +5 more
wiley +1 more source
Clinical study and skin tests of patients with drug eruptions
Background: Drug reactions are common problems in hospital inpatients and outpatients. Reliable diagnosis is essential but often difficult. Objective: This study attempts to define the clinical features and causative drugs in the patients with drug ...
명기범, 최혜영
core +1 more source
Iododerma after Lugol use for pre-operative preparation of thyroidectomy
A 35-year-old man with hyperthyroidism reported the sudden occurrence of ulcerated and painful oral lesions, painful ulcerative-necrotic lesions on the face, trunk, upper and lower limbs and purpuric circinate lesions on the scalp, 6 days after starting ...
David Almeida +6 more
doaj

